James Mitchell Honored by Peers

Mitchell Honored by Peers As Among Best Lawyers in America We are pleased to announce that James A. Mitchell has for the twenty third year in a row been selected by his peers for inclusion in the 24th Edition of Best Lawyers in America in the practice areas of: Litigation – Intellectual Property Law, And […]

Continue Reading

Amanda Osorio Honored

One of 40 Under Forty We are proud to announce that Mitchell IP Law’s Amanda Osorio has been selected as one of the Grand Rapids Business Journal’s 40 Under Forty Business Leaders class of 2017. This year the judges reviewed over 380 nominees. This honor is given to those young professionals who have achieved personal […]

Continue Reading
Virginia-eastern

Mitchell IP LAW Alert – Celebrex Use Patent Invalid

The U.S. District Court for the Eastern District of Virginia invalidated Pfizer’s method-of-use patent on its Celebrex painkiller. The basic chemical patent on Clebrex will lapse May 30, 2014.  Pfizer hoped the method-of-use patent would allow it to maintain market exclusivity on Celebrex through Dec. 2, 2015. Pfizer currently enjoys $3 billion in annual sales from […]

Continue Reading

Mitchell IP Law Alert – Pay To Delay: FTC Finally Bags A Big One

Those engaged in the generic drug business are well familiar with the long term efforts by the Federal Trade Commission to obtain a significant anti-trust judgement in a so-called “Pay to Delay” action.  Cephalon Inc. agreed Thursday to pay $1.2 billion to settle a long-running antitrust suit.  Cephalon was accused of paying generic drug makers […]

Continue Reading

MITCHELL HONORED BY PEERS

MITCHELL HONORED BY PEERS AS AMONG BEST LAWYERS IN AMERICA We are pleased to announce that James A. Mitchell has again been selected by his peers for inclusion in the 21st Edition of Best Lawyers in America in the practice areas of: Litigation – Intellectual Property Law, And Patent and Trademark Law.  This makes more than […]

Continue Reading